You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

Completed
  • Huerthle Cell Carcinoma
    • (no location specified)
    Jul 20, 2023

    Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

    Recruiting
    • Squamous Cell Carcinoma of Oral Cavity
    • +3 more
    • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
    • Gliwice, Silesia, Poland
      The Maria Sklodowska-Curie National Research Institute of Oncolo
    Aug 7, 2023

    Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • KSD-101
    • Wuhan, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 19, 2023

    Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Skin
    • +2 more
    • Marlborough, Massachusetts
      Phio Pharmaceuticals Corp.
    Aug 25, 2023

    Merkel Cell Carcinoma Clinical Trial Engagement Patterns

    Not yet recruiting
    • Merkel Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Sep 8, 2023

      Delving Into Participation Trends in Renal Cell Carcinoma

      Not yet recruiting
      • Renal Cell Carcinoma
        • San Francisco, California
          Power Life Sciences
        Oct 16, 2023

        Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

        Not yet recruiting
        • Pancreatic Adenocarcinoma
        • +6 more
        • (no location specified)
        Aug 4, 2023

        Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

        Recruiting
        • Nasopharyngeal Carcinoma
        • Endostar and Envafolimab
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer Hospital
        Sep 24, 2023

        Hepatocellular Carcinoma Trial in Yerevan

        Recruiting
        • Hepatocellular Carcinoma
          • Yerevan, Armenia
            Nikomed Medical Center
          Jun 28, 2023

          Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

          Recruiting
          • Hepatocellular Carcinoma
          • Seoul, Korea, Republic of
            Asan Medical Center
          Nov 14, 2023

          Resectable Hepatocellular Carcinoma Trial in Jakarta Pusat (Liver Resection)

          Completed
          • Resectable Hepatocellular Carcinoma
          • Liver Resection
          • Jakarta Pusat, DKI Jakarta, Indonesia
            Dr. Cipto Mangunkusumo General Hospital
          Aug 24, 2023

          Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • no intervention
          • Wuhan, Hubei, China
            Renmin hosptial of Wuhan University
          Jul 29, 2023

          Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

          Not yet recruiting
          • Advanced Esophageal Squamous Carcinoma With Oligometastases
          • simultaneous with radiotherapy
          • synchronous with radiotherapy
          • (no location specified)
          Nov 16, 2023

          Advanced Hepatocellular Carcinoma Trial (CD-801)

          Not yet recruiting
          • Advanced Hepatocellular Carcinoma
          • (no location specified)
          Oct 13, 2023

          Immunotherapy in Upper Tract Urothelial Carcinoma

          Not yet recruiting
          • Urothelial Carcinoma
          • Evaluation of anti-PD-(L)1 immunotherapy efficacy
          • (no location specified)
          Oct 27, 2023

          Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

          Not yet recruiting
          • Squamous Cell Carcinoma
            • San Francisco, California
              Power Life Sciences
            Jun 23, 2023

            Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

            Not yet recruiting
            • Esophageal Squamous Cell Carcinoma
            • Shanghai, Shanghai, China
              Fudan University Shanghai Cancer Center
            Nov 30, 2023

            Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

            Recruiting
            • Esophageal Squamous Cell Carcinoma
              • Shijiazhuang, Hebei, China
                Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
              Oct 25, 2023

              Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

              Recruiting
              • Esophageal Squamous Cell Carcinoma
              • Head and Neck Squamous Cell Carcinoma
              • Chengdu, Sichuan, China
                West China Hospital, Sichuan University
              Oct 25, 2023

              Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

              Recruiting
              • Liver Carcinoma
              • Hepatic Cell Carcinoma
              • CAR-GPC3 T cells
              • Wuhan, Hubei, China
                Tao Zhang
              Nov 20, 2023

              Cirrhosis, Liver Trial (Epigallocatechin gallate (EGCG), Placebo)

              Not yet recruiting
              • Cirrhosis, Liver
              • Epigallocatechin gallate (EGCG)
              • Placebo
              • (no location specified)
              Aug 27, 2023

              Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

              Recruiting
              • Unresectable Hepatocellular Carcinoma
              • Yttrium-90 carbon microspheres SIRT
              • Nanjing, China
                Gao-Jun Teng
              Jul 20, 2023

              Process for Hepatocellular Carcinoma

              Not yet recruiting
              • Hepatocellular Carcinoma
                • (no location specified)
                May 5, 2023

                Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

                Recruiting
                • Metastatic Esophageal Squamous Cell Carcinoma
                • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
                • Qingdao, Shandong, China
                • +1 more
                Nov 13, 2023

                Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

                Not yet recruiting
                • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
                • Guangzhou, Guangdong, China
                  Sun Yat-sen University
                Oct 24, 2023